McGuinness, L
Eisa N, Barood O
Comparatively, Glucagon-like Peptide-1 (GLP-1) agonists, such as liraglutide and semaglutide, primarily work by enhancing insulin secretion, inhibiting glucagon release, promoting weight loss, and improving lipid levels
Loss of exercise consistency
Consumers should discuss compounded medication status, dosing, risks, alternatives, and pharmacy fulfillment with their assigned licensed provider before starting any compounded medication
comparing liraglutide 1.2 mg/day + metformin 1000 mg BID with liraglutide 3 mg/day, the combination therapy was effective in reducing fasting glucose and insulin, HOMA-IR, and LDL cholesterol, while only the high dose of liraglutide resulted in a significant improvement of 120 min during OGTT glucose and insulin levels along with a higher weight loss [63]